Wave Life Sciences Ltd. Ordinary Shares
Here’s whether Wave Life Sciences Ltd. Ordinary Shares (WVE) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Positives: strong 1-year return of +28.2%. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-9.73% over 10 days); 3-month momentum negative (-45.1%). Currently 65.5% off its 52-week high. Score: -4/7.
WVE is trading below its 200-day MA ($10.22) — a key warning sign the longer-term trend is under pressure. An RSI of 69.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +28.3% compares to +35.1% for SPY (trailed the market by 6.8%). The current 65.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.